ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
86,310.01
-0.51%
S&P 500
5,770.20
0.55%
Dow Jones
42,801.72
0.52%
US Dollar vs Yen
148.055
0.03%
Brent Oil
70.235
0.00%
Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Standard BioTools Inc (LAB)

  7. Standard BioTools Inc (LAB) ニュース

LAB

Standard BioTools (LAB)

Standard BioTools Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:LAB
日付受信時刻ニュースソース見出しコード企業名
2025/03/0509 : 46Edgar (US Regulatory)Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:LABStandard BioTools Inc
2025/03/0507 : 52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
2025/03/0507 : 51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
2025/02/2806 : 01GlobeNewswire Inc.Standard BioTools to Participate in Upcoming Investor ConferencesNASDAQ:LABStandard BioTools Inc
2025/02/2706 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LABStandard BioTools Inc
2025/02/2706 : 01GlobeNewswire Inc.Standard BioTools Reports Fourth Quarter and Full Year 2024 Financial ResultsNASDAQ:LABStandard BioTools Inc
2025/02/2507 : 30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
2025/02/1221 : 00GlobeNewswire Inc.Standard BioTools Schedules Fourth Quarter and Full Year 2024 Earnings Conference Call on February 26, 2025NASDAQ:LABStandard BioTools Inc
2025/01/1321 : 08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LABStandard BioTools Inc
2025/01/1321 : 00GlobeNewswire Inc.Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2024 RevenueNASDAQ:LABStandard BioTools Inc
2025/01/1106 : 09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LABStandard BioTools Inc
2025/01/0821 : 00GlobeNewswire Inc.Standard BioTools SomaScan Assay Powers Key Insights into Semaglutide Treatment Published in Nature MedicineNASDAQ:LABStandard BioTools Inc
2024/12/2106 : 14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LABStandard BioTools Inc
2024/12/1922 : 00GlobeNewswire Inc.Standard BioTools to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:LABStandard BioTools Inc
2024/11/2210 : 55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
2024/11/1505 : 32Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:LABStandard BioTools Inc
2024/11/1306 : 13Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LABStandard BioTools Inc
2024/11/0722 : 06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LABStandard BioTools Inc
2024/11/0722 : 00GlobeNewswire Inc.Standard BioTools Appoints Alex Kim as Chief Financial OfficerNASDAQ:LABStandard BioTools Inc
2024/11/0707 : 17Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LABStandard BioTools Inc
2024/10/3121 : 01GlobeNewswire Inc.Standard BioTools to Participate in Upcoming Investor ConferencesNASDAQ:LABStandard BioTools Inc
2024/10/3105 : 17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LABStandard BioTools Inc
2024/10/3105 : 01GlobeNewswire Inc.Standard BioTools Reports Third Quarter 2024 Financial ResultsNASDAQ:LABStandard BioTools Inc
2024/10/2503 : 02Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:LABStandard BioTools Inc
2024/10/2205 : 26Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:LABStandard BioTools Inc
2024/10/1621 : 00GlobeNewswire Inc.Standard BioTools Announces Conference Call and Webcast for Third Quarter 2024 Financial Results on October 30, 2024NASDAQ:LABStandard BioTools Inc
2024/09/2421 : 00GlobeNewswire Inc.Standard BioTools Achieves New Record of the Most Protein Measurements on the Most Sample Types with Expansion of the SomaScan® 11K PlatformNASDAQ:LABStandard BioTools Inc
2024/09/1821 : 00GlobeNewswire Inc.Standard BioTools proteomics profiling reveals unique biomarkers and insights into nonalcoholic steatohepatitis (NASH)NASDAQ:LABStandard BioTools Inc
2024/09/1004 : 19Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LABStandard BioTools Inc
2024/09/0607 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
 Showing the most relevant articles for your search:NASDAQ:LAB

最近閲覧した銘柄

NASDAQ
QQQ
Invesco QQQ Trust Series 1
USOTC
BASFY
BASF (QX)
NYSE
AXP
American Express
AMEX
SPY
SPDR S&P 500
NASDAQ
AAPL
Apple
FX
USDGBP
US Dollar vs Sterling
NYSE
KO
Coca Cola
NASDAQ
GOOGL
Alphabet
NYSE
MRK
Merck
USOTC
BNPQY
BNP Paribas (QX)
NYSE
MCD
McDonalds
USOTC
DTEGY
Deutsche Telekom (QX)
COIN
AVAXUSD
Avalanche
NYSE
DIS
Walt Disney
COIN
ETHUSD
Ethereum
FX
USDEUR
US Dollar vs Euro
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2025 ADVFN PLC - 全著作権所有

広告を削除する

サインアップして広告なしのエクスペリエンスを体験してください

広告なし

今すぐ試してください

広告を残す